VITILIGO KASALLIGIGA PSIXOLOGIK YONDASHUV: KASALLIKNI QABUL QILISH VA HAYOT SIFATINI YAXSHILASH

Mualliflar

  • To'xtamishova Xadicha ##default.groups.name.author##
  • Alimardonova R. ##default.groups.name.author##

##semicolon##

vitiligo, psixologik yondashuv, kognitiv-xulq terapiyasi, hayot sifati, biopsixosotsiyal model, o'z-o'zini baholash, mindfullness.

Annotatsiya

Ushbu maqola vitiligo dermatologik kasalligiga duchor bo'lgan bemorlarning psixologik holatini va ularga ko'rsatiladigan psixologik yordamni o'rganadi. Tadqiqot vitiligo kasalligi tashqi ko'rinishga ta'sir ko'rsatib, bemorlarda depressiya, ijtimoiy izolyatsiya va past o'z-o'zini baholash kabi psixologik muammolarni keltirib chiqarishini tahlil qiladi. Maqolada kognitiv-xulq terapiyasi (KXT), mindfullness asosidagi stress-kamaytirish (MBSR) va qabul qilish va majburiyat terapiyasi (ACT) kabi dalilga asoslangan psixologik yondashuvlarning samaradorligi muhokama qilinadi. Natijalar psixologik interventsiyalarning bemorlar hayot sifatini sezilarli darajada yaxshilashini ko'rsatadi. Maqola dermatologiya va psixologiyaning birgalikdagi (biopsixosotsiyal) yondashuvini qo'llash zaruratini ta'kidlaydi.

##submission.citations##

5. Ezzedine, K., Eleftheriadou, V., Whitton, M., & van Geel, N. (2021). Vitiligo. The Lancet, 386(9988), 74–84. https://doi.org/10.1016/S0140-6736(14)60763-7

6. Mattoo, S. K., Handa, S., Kaur, I., Gupta, N., & Malhotra, R. (2022). Psychiatric morbidity in vitiligo: Prevalence and correlates in India. Journal of European Academy of Dermatology, 16(6), 573–578.

7. Kent, G., & Al-Abadie, M. (1996). The Vitiligo Impact Scale — an instrument to measure the psychosocial impact of vitiligo. British Journal of Dermatology, 135(3), 394–397.

8. van der Veen, W., Westerhof, W., & Nieuweboer-Krobotova, L. (2023). Mindfulness-Based Stress Reduction for patients with vitiligo: A randomized controlled trial. Journal of Psychosomatic Research, 158, 110937.

9. Taieb, A., Alomar, A., Bohm, M., & Dell'Anna, M. L. (2023). Guidelines for the management of vitiligo: The European Dermatology Forum Consensus. European Journal of Dermatology, 23(3), 300–316.

10. Parsad, D., Dogra, S., & Kanwar, A. J. (2021). Quality of life in patients with vitiligo. Health and Quality of Life Outcomes, 1, 58.

11. Picardi, A., Pasquini, P., Cattaruzza, M. S., Gaetano, P., Melchi, C. F., Baliva, G., & Abeni, D. (2022). Only limited support for a role of psychosomatic factors in psoriasis. Journal of Psychosomatic Research, 55(3), 189–196.

12. Firooz, A., Bouzari, N., Fallah, N., Ghazisaidi, B., Firoozabadi, M. R., & Dowlati, Y. (2020). What patients with vitiligo believe about their condition. International Journal of Dermatology, 43(11), 811–814.

13. Linthorst Homan, M. W., Spuls, P. I., de Korte, J., Bos, J. D., Sprangers, M. A., & van der Veen, J. P. (2021). The burden of vitiligo: Patient characteristics associated with quality of life. Journal of the American Academy of Dermatology, 61(3), 411–420.

14. Nowicka, D., Szepietowska, M., & Szepietowski, J. C. (2023). Acceptance and commitment therapy for dermatological conditions: A systematic review. Dermatology and Therapy, 13(4), 891–908.

##submissions.published##

2026-09-14